Lupin Q1 results: Net profit jumps 52% to ₹1,221 cr on strong sales in US

The drug maker reported a profit after tax (PAT) of ₹805 crore in the April-June quarter of last fiscal

​The drug maker reported a profit after tax (PAT) of ₹805 crore in the April-June quarter of last fiscal